Trilineage response to rhG-CSF with subsequent clonal hematopoiesis in a patient with severe bone marrow aplasia

Leuk Lymphoma. 1994 Jul;14(3-4):347-51. doi: 10.3109/10428199409049689.

Abstract

We treated a patient with severe aplastic anemia with long-term administration of recombinant human granulocyte-colony stimulating factor (rhG-CSF). When a trilineage response of hematopoiesis was obtained after the first treatment, a chromosomal change [45XX, -7] was observed in 20 of the 20 metaphases examined. Later, we were able to show a monoclonal X inactivation pattern in the phosphoglycerate kinase (PGK) gene in the peripheral blood polymorphonuclear leukocytes and mononuclear cells, indicating the presence of clonal hematopoiesis regardless of the disappearance of the karyotype abnormality. We suggest that it is important to pay close attention to the appearance of clonal hematopoiesis during the administration of G-CSF to patients with idiopathic severe bone marrow aplasia.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anemia, Aplastic / drug therapy*
  • Anemia, Aplastic / genetics
  • Bone Marrow / drug effects
  • Bone Marrow / physiology
  • Chromosome Aberrations*
  • Drug Administration Schedule
  • Female
  • Granulocyte Colony-Stimulating Factor / adverse effects*
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Hematopoiesis / drug effects*
  • Hematopoiesis / physiology*
  • Humans
  • Karyotyping
  • Leukocytes, Mononuclear / drug effects
  • Leukocytes, Mononuclear / physiology
  • Neutrophils / drug effects
  • Neutrophils / physiology
  • Recombinant Proteins / therapeutic use

Substances

  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor